Teva Gets Nod For $24M Nexium Pay-For-Delay Settlement
A Massachusetts federal judge on Friday gave tentative approval to a $24 million settlement between Teva Pharmaceutical Industries Ltd. and class action plaintiffs in a pay-for-delay case over generic versions of...To view the full article, register now.
Already a subscriber? Click here to view full article